Rua Bioscience FY21 Results to be Announced 30 August 2021

FOR PUBLIC RELEASE
NZX Limited
Wellington

12 August 2021


Rua Bioscience FY21 results to be announced on 30 August 2021

Rua Bioscience Ltd (NZX:RUA) intends to announce its results for the 12 months ended 30 June
2021 (FY21) on 30 August 2021.

This will be followed by an investor conference call at 11am at which management will review the
FY21 results and discuss the Company’s performance and outlook.

Register for the call at: https://s1.c-conf.com/diamondpass/10015791-mas1pa9.html

Participants will receive the dial-in number and personal pin upon registration, allowing direct
entry to the call. A calendar invitation will be emailed together with a reminder email prior to the
call.

If you do not pre-register in advance then, at the time of the conference, you should:

Dial: Auckland: 09 929 1687
Christchurch: 03 974 2632
Wellington: 04 974 7738

Provide conference ID:
10015791


We recommend dialling in 10 minutes prior to the scheduled call time.

ENDS

For further information, please contact:
Hamish White
Rua Bioscience CFO
0800 RUA BIO
Hamish.white@ruabio.com

For media or investor enquiries, please contact:
Kerry Donovan
Communications Manager
Kerry.donovan@ruabio.com

About Rua
Rua Bioscience (RUA:NZX) is a New Zealand pharmaceutical company that is a pioneer in the
New Zealand medicinal cannabis sector. Established in 2017 to support economic development in
Te Tairāwhiti, Rua holds a licence to operate in the medicinal cannabis sector commercially, has
MARKET ANNOUNCEMENT

two commercial-scale facilities and holds an exclusive contract with German distributer Nimbus
Health to supply dried flower. Rua’s extensive knowledge of the global market and expertise in:
cannabis plant chemistry and analytics; cultivation and growth optimisation; and processing and
pharmaceutical manufacturing supports its strategy to identify long-term value opportunities in
agritech. www.ruabio.com